Hemophilia and Blood Clotting Institute

The Hemophilia and Blood Clotting Institute is a national center that provides care to around 700 hemophiliacs annually. Additionally, we offer treatment to approximately 1,000 patients with other blood diseases and thousands more with thrombosis, hypercoagulability, as well as adults and children undergoing anticoagulant therapy. 

Our staff has earned international recognition in the fields of hemophilia and coagulation and is considered a leading international center for pediatric coagulation. The institute is renowned within the field of hemophilia for its expertise in treatment, diagnosis, and research. We proudly serve as a training hub for expert hematologists nationwide, and as an esteemed international training centre, providing instruction to physicians and physiotherapists from hemophilia units worldwide.

The institute is also a world-leading centre of excellence in clinical research, including multi-centre international trials, which contribute to the development of innovative treatment approaches. In 2019, together with centres in the United States and the United Kingdom, we initiated a program of gene therapy studies in hemophiliacs.

What makes Sheba the ideal place for treatment?

The treatment of hemophilia calls for a highly skilled and experienced team of professionals. This includes hematologists, liver specialists, AIDS specialists, orthopedists, physiotherapists, psychosocial staff, and dedicated nursing staff. At Sheba’s center for Hemophilia and Blood Clotting, we specialize in caring for patients with severe and rare deficiencies in coagulation factors and blood platelet disorders. We warmly accept patient referrals from across the country.

Our team of experts at Sheba is highly professional and skilled in the treatment of various diseases. Their expertise extends to receiving consultations from leading international centers on unique issues, such as coagulation disorders in children, problematic cases of hemophilia, factor XI deficiency, factor VII deficiency, Glanzmann thrombasthenia, and other related conditions.

The doctors on our staff have specialized in treating life-threatening blood conditions and trauma patients, and routinely provide real-time advice on this subject to various centers in Israel. Our experts are invited to international conferences and serve on steering and research committees of international associations (ISTH).

Sheba is one of the world's leading centers in hemophilia research, and our research unit has successfully passed two FDA (American Food and Drug Administration) audits. We are the only center in Israel, and one of the first in the world, providing genetic therapy to cure hemophilia.